Pharmacokinetics, metabolism and excretion of [14C]-lanicemine (AZD6765), a novel low-trappingN-methyl-d-aspartic acid receptor channel blocker, in healthy subjects-Reference-Cited by-同舟云学术

Pharmacokinetics, metabolism and excretion of [14C]-lanicemine (AZD6765), a novel low-trappingN-methyl-d-aspartic acid receptor channel blocker, in healthy subjects

Published:2014-09-26 Issue:3 Volume:45 Page:244-255
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Guo Jian,Zhou Diansong,Grimm Scott W.,Bui Khanh H.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2014.966175

Reference26 articles.

1. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

2. Plasma and platelet excitatory amino acids in psychiatric disorders

3. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective detection of aspartic acid in human serum by a fluorescent probe based on CuInS2@ZnS quantum dots;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-04

2. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023

3. NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats;Psychopharmacology;2019-07-02

4. Beyond serotonin: newer antidepressants in the future;Expert Review of Neurotherapeutics;2017-06-19

5. Population pharmacokinetic analysis of lanicemine (AZD6765), an NMDA channel blocker, in healthy subjects and patients with major depressive disorder;Journal of Clinical Pharmacy and Therapeutics;2017-05-04